Fraud in pharmaceutical sales
Our firm has been hired by the State’s of Alabama, Mississippi, South Carolina, Utah, Alaska, and Hawaii to represent them in Average Wholesale Pricing (AWP) litigation.
This type of litigation involves the fraudulently inflated pricing of drugs by pharmaceutical companies to state agencies and private health insurance plans. The flagrant misrepresentations by the drug companies that have been revealed in these types of cases mainly by “whistleblowers” are appalling. So called “AWP (average wholesale price)” cases and “PBM (Pharmacy Benefits Manger)” cases, though distinct claims, both involved price gouging, failure to deliver on contractual rebates and misrepresentations about the products and/or plans benefits.
Our firm has represented the State of Alabama against some 79 pharmaceutical companies for fraudulently settling their “reimbursement” prices to the level of costing the state over $600 million in over-payments.We have successfully defeated the industry’s attempts to move this litigation to a Boston federal court, where many other states have unfortunately been forced to litigate their similar claims. Our firm is assisting other states with their claims, which will likely result in litigation as well.
What can I do?
We enjoy a distinct national reputation for excellence in the area of consumer fraud litigation. This litigation includes individual cases as well as class actions that have been filed throughout the country. Most of the cases involve wrongful conduct of insurance and finance companies including fraud and bad faith. We are also a national leader in the fight against mandatory binding arbitration in consumer contracts.
If you or a loved one has become a victim of consumer fraud, you may be entitled to compensation. For a free legal consultation, contact us today!